Company Overview and News

2
ASX advances on bank strength as CSL breaks $200

2018-07-12 theage.com.au
The Australian sharemarket has closed higher despite an overnight commodity plunge that saw Brent crude prices record their biggest fall in two years.
WOPEF RIO BLT RIO OGFGY BEPTF RTPPF RTNTF TWE TSRYY BHPBF WTCHF WPL BCHEY WOPEY BPT TSRYF TNE BHP RIO BBL BHP OGFGF BHPLF ORG

2
ASX advances on bank strength as CSL breaks $200

2018-07-12 smh.com.au
The Australian sharemarket has closed higher despite an overnight commodity plunge that saw Brent crude prices record their biggest fall in two years.
WOPEF RIO BLT RIO OGFGY BEPTF RTPPF RTNTF TWE TSRYY BHPBF WTCHF WPL BCHEY WOPEY BPT TSRYF TNE BHP RIO BBL BHP OGFGF BHPLF ORG

2
Australian shares advance on strength of major banks

2018-07-03 theage.com.au
The Australian sharemarket has recorded only its second advance in the last eight sessions despite a broad retreat of commodity prices overnight.
PILBF RIO DB BLT RIO IAG MS.PRE MS.PRF MS.PRG MS.PRA BEPTF RTPPF GALXF RTNTF MS TWE SML IAUGY PLS TSRYY BHPBF EBOSY EBO BCHEY BPT EBOSF TSRYF GXY IAUGF MS.PRI BHP RIO MS.PRK BBL BHP BHPLF EBO

2
Australian shares advance on strength of major banks

2018-07-03 smh.com.au
The Australian sharemarket has recorded only its second advance in the last eight sessions despite a broad retreat of commodity prices overnight.
PILBF RIO DB BLT RIO IAG MS.PRE MS.PRF MS.PRG MS.PRA BEPTF RTPPF GALXF RTNTF MS TWE SML IAUGY PLS TSRYY BHPBF EBOSY EBO BCHEY BPT EBOSF TSRYF GXY IAUGF MS.PRI BHP RIO MS.PRK BBL BHP BHPLF EBO

0
Full-bodied move by Penfolds comes with risk

2018-07-03 theage.com.au
If Penfolds’ flagship Grange were made with grapes sourced from the Napa Valley would it still be regarded in the same revered light? That’s not quite the question Treasury Wine Estates is posing to wine connoisseurs but the decision to source Penfolds-branded products from outside Australia for the first time is a bold and potentially risky one.
TSRYY TSRYF TWE

0
Full-bodied move by Penfolds comes with risk

2018-07-03 smh.com.au
If Penfolds’ flagship Grange were made with grapes sourced from the Napa Valley would it still be regarded in the same revered light? That’s not quite the question Treasury Wine Estates is posing to wine connoisseurs but the decision to source Penfolds-branded products from outside Australia for the first time is a bold and potentially risky one.
TSRYY TSRYF TWE

3
Australia to pass foreign interference laws amid rising China tensions

2018-06-27 theedgemarkets
SYDNEY/BEIJING (June 27): Australia is expected to pass legislation on Thursday aimed at preventing interference by foreign governments, a move likely to further stoke tensions with major trading partner China.
TSRYY TSRYF TPGTF TPPTY TPM TWE

1
Australia to pass foreign interference bill amid tensions with China | Euronews

2018-06-27 euronews
SYDNEY (Reuters) – Australia is expected to pass new legislation on Wednesday aimed at preventing interference by foreign governments, a move likely to further stoke tensions with major trading partner China.
TSRYY TSRYF TWE RI

1
Australia to pass foreign interference bill amid tensions with China - Channel NewsAsia

2018-06-27 channelnewsasia
Australia is expected to pass new legislation on Wednesday aimed at preventing interference by foreign governments, a move likely to further stoke tensions with major trading partner China.
TSRYY TSRYF TWE RI

0
Chinese telco Huawei lobbies hard to allay Australia's security concerns

2018-06-27 channelnewsasia
Chinese telecom firm Huawei Technologies Co Ltd's network equipment is "safe and secure", its Australian chairman said on Wednesday, ramping up the company's public lobbying against concerns that its links to China pose a security risk.
TSRYY TSRYF TWE

0
Chinese telco Huawei lobbies hard to allay Australia's security concerns

2018-06-27 reuters
SYDNEY (Reuters) - Chinese telecom firm Huawei Technologies Co Ltd’s [HWL.UL] network equipment is “safe and secure”, its Australian chairman said on Wednesday, ramping up the company’s public lobbying against concerns that its links to China pose a security risk.
TSRYY TSRYF TWE

9
The Wine Industry In 20 Years: Will Blenders Be King?

2018-06-22 seekingalpha
1. Research has shown no correlation between price and the wines people like. From blind tastings in Paris (1976), Princeton (2012), Stellenbosch (2013), The Lenox Wine Club (2012-14), Lecocq and Visser, Goldstein et al, and Ashton, we have learned that “expert” and “amateur” drinkers do not prefer expensive wines to less expensive ones: there is no correlation between price and how people rate wines.
TSRYY VCO TSRYF GIS STZ TWE DEO

0
Chinese ambassador calls on Australia to drop 'Cold War mentality' | Euronews

2018-06-19 euronews
CANBERRA/SYDNEY (Reuters) – China’s ambassador to Australia said on Tuesday “less bias and bigotry” was needed to repair bilateral relations amid concerns over Chinese influence in Australia and its use of loans to build leverage over poorer South Pacific island nations.
TSRYY TSRYF TWE

0
Chinese ambassador calls on Australia to drop 'Cold War mentality'

2018-06-19 theedgemarkets
CANBERRA/SYDNEY (June 19): China's ambassador to Australia said on Tuesday "less bias and bigotry" was needed to repair bilateral relations amid concerns over Chinese influence in Australia and its use of loans to build leverage over poorer South Pacific island nations.
TSRYY TSRYF TWE

0
Chinese ambassador calls on Australia to drop 'Cold War mentality'

2018-06-19 channelnewsasia
CANBERRA/SYDNEY: China's ambassador to Australia said on Tuesday "less bias and bigotry" was needed to repair bilateral relations amid concerns over Chinese influence in Australia and its use of loans to build leverage over poorer South Pacific island nations.
TSRYY TSRYF TWE

Related Articles

CATB: Catabasis Pharmaceuticals Analysis and Research Report

2018-07-13 - Asif

Overview Catabasis Pharmaceuticals is a clinical-stage biopharmaceutical company focused on the discovery, development and commercialization of novel therapeutics based on its proprietary Safely Metabolized And Rationally Targeted linker, or SMART LinkerSM, drug discovery platform. The company's SMART Linker drug discovery platform enables it to engineer product candidates that can simultaneously modulate multiple targets in a disease. The company's proprietary product candidates impact pathways that are central to diseases where efficacy may be optimized by a multiple target approach. Catabasis Pharmaceuticals has applied its SMART Linker drug discovery platform to build an internal pipeline of product candidates for rare diseases, its primary focus, and plan to pursue partnerships to develop additional product candidates. The company's lead product candidate is edasalonexent, formerly known as CAT-1004, which the company believe has the potential to be a disease-modifying...

WMT: Walmart Analysis and Research Report

2018-07-09 - Asif

Overview Walmart Inc. helps people around the world save money and live better – anytime and anywhere – in retail stores and through eCommerce. Through innovation, Walmart is striving to create a customer-centric experience that seamlessly integrates its eCommerce and retail stores in an omni-channel offering that saves time for its customers. Each week, the company serve nearly 270 million customers who visit its more than 11,700 stores and numerous eCommerce websites under 65 banners in 28 countries. The company's strategy is to lead on price, invest to differentiate on access, be competitive on assortment and deliver a great experience. Leading on price is designed to earn the trust of its customers every day by providing a broad assortment of quality merchandise and services at everyday low prices ("EDLP"). EDLP is its pricing philosophy under which the company price items at a low price every day so its customers trust that its prices will not change under frequent prom...

NVRO: Nevro Corp Analysis and Research Report

2018-07-06 - Asif

Overview Nevro is a global medical device company focused on providing innovative products that improve the quality of life of patients suffering from chronic pain. Nevro has developed and commercialized the Senza® spinal cord stimulation (SCS) system, an evidence-based neuromodulation platform for the treatment of chronic pain. The company's proprietary paresthesia-free HF10TM therapy, delivered by its Senza system, was demonstrated in its SENZA-RCT study to be superior to traditional SCS therapy with it being nearly twice as successful in treating back pain and 1.5 times as successful in treating leg pain when compared to traditional SCS therapy. Comparatively, traditional SCS therapy has limited efficacy in treating back pain and is used primarily for treating leg pain, limiting its market adoption. The company's SENZA-RCT study, along with its European studies, represents what the company believe is the most robust body of clinical evidence for any SCS therapy. The compa...

CUSIP: AAB61JC64